{
    "Trade/Device Name(s)": [
        "KeyPath MRSA/MSSA Blood Culture Test - BT",
        "MicroPhage MRSA/MSSA Blood Culture Test-BT",
        "KeyPath AST"
    ],
    "Submitter Information": "MicroPhage, Inc.",
    "510(k) Number": "K102342",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071026",
        "K851949",
        "K011710"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "OUS"
    ],
    "Summary Letter Date": "May 3, 2011",
    "Summary Letter Received Date": "May 3, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.2050"
    ],
    "Regulation Name(s)": [
        "Staphylococcal typing bacteriophage"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Staphylococcus aureus",
        "Methicillin-resistant Staphylococcus aureus (MRSA)",
        "Methicillin-sensitive Staphylococcus aureus (MSSA)"
    ],
    "Specimen Type(s)": [
        "Positive blood culture"
    ],
    "Specimen Container(s)": [
        "BD BACTEC blood culture bottles (Plus Aerobic/F and Plus Anaerobic/F)"
    ],
    "Instrument(s)/Platform(s)": [
        "KeyPath MRSA/MSSA Blood Culture Test BT"
    ],
    "Method(s)/Technology(ies)": [
        "Bacteriophage amplification",
        "Lateral flow immunoassay"
    ],
    "Methodologies": [
        "Phenotypic susceptibility testing"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for KeyPath MRSA/MSSA Blood Culture Test BT for qualitative identification and susceptibility of S. aureus from positive blood cultures using bacteriophage amplification and immunoassay.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for timely identification of S. aureus and determination of methicillin susceptibility (MSSA) or resistance (MRSA) directly from positive blood cultures, using bacteriophage amplification and cefoxitin, as an aid in detection in conjunction with other laboratory and clinical data.",
    "fda_folder": "Microbiology"
}